Clinical Evaluation of 1-Hydrazinophthalazin (C-5968) in Hypertension
- 1 June 1952
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 5 (6), 833-841
- https://doi.org/10.1161/01.cir.5.6.833
Abstract
Single oral doses of 1-hydrazinophthalazine frequently lowered blood pressure particularly diastolic pressure in hypertensive patients. Prolonged therapy was less successful, apparently as a result of development of tolerance or side effects. The best long-term results were obtained when l-hydrazinophthalazine was alternated with hexamethonium.Keywords
This publication has 11 references indexed in Scilit:
- The Treatment of Hypertension with HexamethoniumCirculation, 1952
- METHONIUM COMPOUNDS IN HYPERTENSIONThe Lancet, 1951
- Treatment of Severe Hypertension with Hexamethonium BromideBMJ, 1950
- Suppression of Vasomotor Reflexes in Man Following L-Hydrazinophthalozine (C-5968).Experimental Biology and Medicine, 1950
- Eine neue Gruppe blutdrucksenkender Substanzen von besonderem WirkungscharakterCellular and Molecular Life Sciences, 1950
- OBSERVATIONS ON THE DEVELOPMENT OF TOLERANCE DURING PROLONGED ORAL ADMINISTRATION OF DIHYDROERGOCORNINE1949
- A clinical evaluation of veratrum viride in the treatment of essential hypertensionAmerican Heart Journal, 1948
- Treatment of hypertensive vascular disease with rice dietAmerican Journal Of Medicine, 1948
- The Pharmacological Basis of Therapeutics.Anesthesia & Analgesia, 1941